Find clinical trials for Alzheimer's Disease in Ann Arbor, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Ann Arbor, MI, USA:
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Ann Arbor, Michigan, United States and 50 other locations
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Ann Arbor, Michigan, United States and 108 other locations
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...
Phase 2, Phase 3
Rochester Hills, Michigan, United States and 149 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Farmington Hills, Michigan, United States of America and 127 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Ann Arbor, Michigan, United States and 145 other locations
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Bloomfield Township, Michigan, United States and 310 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Farmington Hills, Michigan, United States of America and 149 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Troy, Michigan, United States and 252 other locations
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Farmington Hills, Michigan, United States of America and 228 other locations
of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's...
Phase 4
Farmington Hills, Michigan, United States of America and 13 other locations
Clinical trials
Research sites
Resources
Legal